This feels a bit like an advert
It's important to note that thyroid hormone should never be prescribed to treat obesity in people with normal thyroid function, as this is unsafe and carries an FDA boxed warning
Glutathione S-transferases have been shown to be induced by a wide range of chemical agents (Ulmasov et al, 1995), wounding, heavy metals, ethylene, and ozone (Marrs, 1996)
This mechanism creates the feeling of fullness that supports weight loss, but it also delays digestion
Small-scale clinical trials revealed that GLP-1 and GLP-1-based medicines may have positive effects on low-grade inflammation, blood pressure, cholesterol, and microcirculation ( Due to their various modes of action, which include vasodilation, natriuresis, glucose and weight control, and direct cardioprotective effects, GLP-1 receptor agonists have therapeutic potential for treatment of heart failure ( Obesity is a major cause of cardiovascular diseases